OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial - Archive ouverte HAL Access content directly
Conference Papers Retrovirology Year : 2009

OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

(1, 2) , (3) , (1) , (4) , (5) , (1) , (6) , (7) , (8) , (9) , (5) , (5) , (5) , (1) , (3) , (5) , (1)
1
2
3
4
5
6
7
8
9

Abstract

n.a

Domains

Life Sciences [q-bio] Human health and pathology Infectious diseases
Fichier principal
Vignette du fichier
1742-4690-6-S3-O25.pdf (169.46 Ko) Télécharger le fichier
Vignette du fichier
1742-4690-6-S3-O25.xml (8.05 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Ed. BMC  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-00663582

Submitted on : Friday, January 27, 2012-1:19:34 PM

Last modification on : Thursday, August 4, 2022-5:26:59 PM

Long-term archiving on: Saturday, April 28, 2012-2:26:33 AM

Download

Dates and versions

inserm-00663582 , version 1 (27-01-2012)

Identifiers

Cite

Dominique Salmon-Céron, Christine Durier, Corinne Desaint, Lise Cuzin, Mathieu Surénaud, et al.. OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial. AIDS Vaccine 2009, Oct 2009, Paris, France. pp.O25, ⟨10.1186/1742-4690-6-S3-O25⟩. ⟨inserm-00663582⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM CNRS UPEC SORBONNE-UNIVERSITE SU-MEDECINE UNIV-PARIS UP-SANTE
182 View
179 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More